Budesonide vs. Mesalazine vs. Budesonide/Mesalazine Suppository Combination Therapy in Acute Ulcerative Proctitis

Proctitis Clinical Trial

Official title:
Randomized, Double-blind, Multicentre Study to Compare the Efficacy and Safety of Budesonide Versus Mesalazine Suppository Versus a Combination Therapy of Budesonide/Mesalazine Suppositories in Patients With Acute Ulcerative Proctitis

Status Completed

Clinical Trial Summary

The purpose of this study is to investigate the efficacy and safety of budesonide suppository for the treatment of acute ulcerative proctitis.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Proctitis

Clinical Trial Details

NCT number	NCT01966783
Study type	Interventional
Source	Dr. Falk Pharma GmbH
Contact
Status	Completed
Phase	Phase 2
Start date	September 2013
Completion date	August 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01008423` - Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis	Phase 3
Completed	`NCT01008410` - Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis	Phase 3
Terminated	`NCT01349673` - The Safety and Tolerability of Budesonide Foam in Participants With Active Ulcerative Proctitis or Proctosigmoiditis	Phase 3
Terminated	`NCT01172444` - Clinical Trial With Mesalamine 1g Suppositories	Phase 3
Completed	`NCT01837615` - Assessment of Photopill Capsule Treatment for Safety and Feasibility in Ulcerative Proctitis	Phase 2